NCT03768089: A reported trial by Vertex Pharmaceuticals Incorporated
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT03768089 |
|---|---|
| Title | A Phase 1/2 Study of VX-121 in Healthy Subjects and in Subjects With Cystic Fibrosis |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | March 20, 2018 |
| Completion date | May 3, 2019 |
| Required reporting date | May 3, 2022, midnight |
| Actual reporting date | April 29, 2022 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |